Crescita Therapeutics Inc. (CTX.TO)

CAD 0.58

(0.0%)

Operating Expenses Summary of Crescita Therapeutics Inc.

Crescita Therapeutics Inc.'s latest annual operating expenses in 2023 was 12.32 Million CAD , down -14.53% from previous year.
Crescita Therapeutics Inc.'s latest quarterly operating expenses in 2024 Q1 was 2.75 Million CAD , down -1.32% from previous quarter.
Crescita Therapeutics Inc. reported a annual operating expenses of 12.65 Million CAD in annual operating expenses 2022, up 17.89% from previous year.
Crescita Therapeutics Inc. reported a annual operating expenses of 10.73 Million CAD in annual operating expenses 2021, up 10.44% from previous year.
Crescita Therapeutics Inc. reported a quarterly operating expenses of 2.75 Million CAD for 2024 Q1, down -1.32% from previous quarter.
Crescita Therapeutics Inc. reported a quarterly operating expenses of 2.79 Million CAD for 2023 Q4, down -2.99% from previous quarter.

Annual Operating Expenses Chart of Crescita Therapeutics Inc. (2023 - 2014)

Historical Annual Operating Expenses of Crescita Therapeutics Inc. (2023 - 2014)

Year	Operating Expenses	Operating Expenses Growth
2023	12.32 Million CAD	-14.53%
2022	12.65 Million CAD	17.89%
2021	10.73 Million CAD	10.44%
2020	9.71 Million CAD	-15.99%
2019	11.56 Million CAD	3.97%
2018	11.12 Million CAD	-16.7%
2017	13.35 Million CAD	-15.13%
2016	15.73 Million CAD	0.13%
2015	15.71 Million CAD	12.04%
2014	14.02 Million CAD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	2.97 Million CAD	18.93%
2024 Q1	2.75 Million CAD	-1.32%
2023 Q4	2.79 Million CAD	-2.99%
2023 FY	10.81 Million CAD	-14.53%
2023 Q3	2.88 Million CAD	-12.59%
2023 Q2	3.29 Million CAD	10.87%
2023 Q1	2.97 Million CAD	-10.29%
2022 Q1	3.08 Million CAD	-12.67%
2022 FY	12.65 Million CAD	17.89%
2022 Q4	3.31 Million CAD	18.11%
2022 Q3	2.8 Million CAD	-18.62%
2022 Q2	3.44 Million CAD	11.63%
2021 FY	10.73 Million CAD	10.44%
2021 Q3	2.38 Million CAD	-0.58%
2021 Q4	3.53 Million CAD	48.26%
2021 Q1	2.41 Million CAD	4.19%
2021 Q2	2.39 Million CAD	-0.58%
2020 Q4	2.31 Million CAD	2.52%
2020 Q2	2.31 Million CAD	-17.95%
2020 FY	9.71 Million CAD	-15.99%
2020 Q1	2.82 Million CAD	3.94%
2020 Q3	2.25 Million CAD	-2.55%
2019 Q3	2.96 Million CAD	-8.43%
2019 Q4	2.71 Million CAD	-8.33%
2019 FY	11.56 Million CAD	3.97%
2019 Q1	2.46 Million CAD	-17.8%
2019 Q2	3.23 Million CAD	31.57%
2018 Q3	2.6 Million CAD	-10.2%
2018 Q4	2.99 Million CAD	14.89%
2018 Q1	2.62 Million CAD	-10.96%
2018 FY	11.12 Million CAD	-16.7%
2018 Q2	2.9 Million CAD	10.59%
2017 Q1	4.11 Million CAD	-21.92%
2017 Q4	2.94 Million CAD	1.38%
2017 FY	13.35 Million CAD	-15.13%
2017 Q3	2.9 Million CAD	-14.3%
2017 Q2	3.39 Million CAD	-17.49%
2016 Q2	3.07 Million CAD	-43.39%
2016 FY	15.73 Million CAD	0.13%
2016 Q4	5.26 Million CAD	57.02%
2016 Q1	5.42 Million CAD	-48.81%
2016 Q3	3.35 Million CAD	9.11%
2015 Q4	10.6 Million CAD	369.78%
2015 Q2	5.61 Million CAD	140.13%
2015 Q3	2.25 Million CAD	-59.83%
2015 FY	15.71 Million CAD	12.04%
2015 Q1	2.34 Million CAD	0.0%
2014 FY	14.02 Million CAD	0.0%

Peer Operating Expenses Comparison of Crescita Therapeutics Inc.

Name	Operating Expenses	Operating Expenses Difference
Aurora Cannabis Inc.	158.53 Million CAD	92.229%
Avicanna Inc.	14.59 Million CAD	15.568%
Avant Brands Inc.	5.65 Million CAD	-117.706%
Cardiol Therapeutics Inc.	29.53 Million CAD	58.29%
Knight Therapeutics Inc.	155.54 Million CAD	92.079%
MediPharm Labs Corp.	23.08 Million CAD	46.627%
OrganiGram Holdings Inc.	277.81 Million CAD	95.565%
Canopy Growth Corporation	308.61 Million CAD	96.008%
Willow Biosciences Inc.	7.55 Million CAD	-63.092%
Auxly Cannabis Group Inc.	40.28 Million CAD	69.416%